Ailsa Craig and Marek Poszepczynski, portfolio managers at the International Biotechnology Trust, tell MoneyWeek where they’d ...

A decades-old TB vaccine turned cancer therapy may unlock new immunotherapies by reprogramming immune cell development in the ...

The test could help direct prostate cancer patients to the best treatment option for them, researchers behind the findings ...

Cardiovascular diseases cause one death every 33 seconds in America. Diagnosing these conditions, which account for ...

Researchers at Helmholtz Munich and the Technical University of Munich have developed a new microscope that significantly ...

With the advancement of medical imaging, the diagnosis and treatment of various conditions have undergone a revolution. Recently, artificial intelligence, ...

CCRPS enhances Medical Science Liaison Certification with live webinars, career center, mentorship, job board—accelerating ...

Since the discovery of penicillin nearly a century ago, antimicrobial resistance (AMR) has become a stealthy, pervasive enemy ...

The first systematic genome-wide association study for pseudogout has identified two genes strongly associated with disease ...

The startup is the latest beneficiary of investors’ appetite for protein-degrading technology, which offers a way to reach ...

Learn how mass spectrometry and data analysis workflows are driving deeper insights into colorectal cancer through ...

PDS Biotechnology Corporation (NASDAQ:PDSB) unveiled compelling new data on its Versamune HPV (PDS0101) immunotherapy at the ...